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Abstract Five 26-peptide analogues of the trypsin inhibitor
[Pro18]CMTI-III containing Leu or Tyr in position 7 and Val or
Tyr in position 27: 1 (Leu7, Tyr27), 2 (Tyr7, Val27), 3 (Tyr7,
Tyr27), 4 (Leu7, Val27) and 5 (Leu7, Ala18, Tyr27) were
synthesized by the solid-phase method. Analogues 1^4 displayed
Ka with bovine L-trypsin of the same order of magnitude as the
wild CMTI-III inhibitor, whereas for analogue 5, this value was
lower by about 3 orders of magnitude. This indicated that for the
analogues with Pro (but not with Ala) in position 18, the side-
chain interactions between positions 7 and 27 did not play a
critical role for the stabilization of the active structure. In
addition, these results also suggest that Tyr7 is involved in an
additional aromatic interaction with position 41 of the enzyme.
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1. Introduction
Trypsin inhibitors CMTI-I and CMTI-III [1] isolated from
squash (Cucurbita maxima) seeds (Fig. 1) were the ¢rst mem-
bers of a new family of serine proteinase inhibitors isolated
from Cucurbitaceae [2]. Because of the small size (about 30
amino acid residues), compact structure (stabilized by three
disul¢de bridges) and strong inhibitory activity (Ka = 1011^
1012 M31) these inhibitors turned out to be very attractive
templates for design of new serine proteinase inhibitors. In
the last decade we synthesized both CMTI-I and CMTI-III
and more than 30 selective trypsin, chymotrypsin and elastase
inhibitors [3^9].
The main problem in the synthesis of CMTI inhibitors was
a poor yield in the oxidation (refolding) process, which was
often not higher than 5%. By the introduction in regions 17^
19 and 23^25 of amino acids which induce L-turn formation
(these secondary structure elements were found in the three-
dimensional structure of CMTI-I [10^12]) we were able to
improve the yield in this process signi¢cantly [5,13]. In our
previous work which aimed at simplifying the structure of
CMTI inhibitors we have also proved that the N-terminal
dipeptide and C-terminal glycine are not essential for trypsin
inhibitory activity [14]. On the other hand, the substitution of
certain amino acid residues by glycine considerably lowered
the association equilibrium constants (Ka) with bovine L-tryp-
sin by over ¢ve orders of magnitude [15]. When we compared
the amino acid sequences of the two sets of CMTI analogues
designed in these two di¡erent approaches, we noticed that in
spite of a high sequence homology, two analogues displayed
dramatically di¡erent trypsin inhibitory activity, measured as
Ka : [desR1,desV2,G9,G17,G19,G23,P24,N25,V27]-CMTI-III (IP)
Ka = 8.1U105 M31 [15]; [desR1,desV2,desG29,G9,G17,P18,G19,
G23,P24,N25,Y27]-CMTI-III (1) Ka = 1.7U1011 M31 [13].
The two analogues di¡er in three positions only. As we
have proved in our previous work [14], the deletion of C-
terminal Gly in the second analogue, does not a¡ect the in-
hibitory activity. We can then assume that for such signi¢cant
di¡erences in the Ka values only two positions, 18 and/or 27,
are responsible. The careful analysis of amino acid sequences
of other inhibitors of the Cucurbitaceae family [5] have shown
a remarkable relation (regularity) between amino acid residues
in positions 7 and 27. In all cases, an aliphatic-aromatic pair
was present. The only exception were the inhibitors isolated
from Momordica charantia where in both positions aromatic
amino acid residues are present but because they also exhibit
the deletion of the dipeptide in the fragment 25^26, their
backbones might fold di¡erently from other members of this
family. The assumption that side chains of amino acid resi-
dues in positions 7 and 27 interact, seemed also to be sup-
ported by the 3D structure of CMTI-I [11] where Leu7 and
Tyr27 side chains are in a close contact (Fig. 2). In view of the
observation discussed we suspected that the dramatically low-
er trypsin inhibitory activity of the ¢rst analogue was caused
by the presence of two aliphatic residues in these positions. In
order to investigate this we decided to synthesize four CMTI
analogues containing all combinations of leucine and tyrosine
in positions 7 and 27. These modi¢cations were introduced
into the previously designed, fully active analogue
[desR1,desV2,desG29,G9,G17,P18,G19,G23,P24,N25]-CMTI-III
(Leu7, Tyr27) (1) [13].
In this paper we consequently describe the synthesis and in-
hibitory activity of the following analogues: [desR1,desV2,
desG29,Y7,G9,G17,P18,G19,G23,P24,N25,V27]-CMTI-III (Tyr7,
Val27) (2) ; [desR1,desV2,desG29,Y7,G9,G17,P18,G19,G23,P24,
N25,Y27]-CMTI-III (Tyr7, Tyr27) (3) ; [desR1,desV2,desG29,G9,
G17,P18,G19,G23,P24,N25,V27]-CMTI-III (Leu7, Val27) (4) ;
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[desR1,desV2,desG29,G9,G17,G19,G23,P24,N25]-CMTI-III
(Leu7, Ala18, Tyr27) (5).
The last analogue (numbered as 5) di¡ers from analogue 1
in one position only. Pro18 present in the ¢rst one is replaced
with the naturally occurring Ala18 residue. It should be
stressed that in both analogues also positions 7 and 27 are
occupied by the amino acid residues (Leu and Tyr, respec-
tively) found in wild CMTI inhibitors. By the synthesis of
analogue 5 and the comparison of its inhibitory activity
with the relevant data obtained for analogue 1 we intended
to investigate the in£uence of position 18 on the binding en-
ergy with bovine L-trypsin.
2. Materials and methods
Amino acid derivatives were supplied by Protein Research Founda-
tion (Osaka, Japan), Bachem Feinchemikalien (CH-4416 Bubendorf)
and Fluka AG (CH-9470 Buchs), and except for Gly were of the L-
con¢guration. Chloromethyl resin with capacity of 0.7 meq/g was
purchased from Fluka AG. Sephadex G-10 and Sephadex G-25
were purchased from Pharmacia Fine Chemicals (S-75104 Uppsala).
Tris was obtained from Serva Feinbiochemica (W-6900 Heidelberg).
Other chemicals used for peptide synthesis and HPLC-grade acetoni-
trile were obtained from Fluka AG. Bz-D,L-Arg-4-nitroanilide, Bz-
Val-Gly-Arg-4-nitroanilide, NPGB and Triton X-100 were obtained
from Sigma Chemical Co. (St. Louis, MO, USA). Bovine L-trypsin
was prepared according to Liepnicks and Light [16].
3. Experimental
3.1. Peptide synthesis
All peptides were synthesized by the solid-phase method
using Boc chemistry. Cleavage of peptides from the resin,
removal of Acm groups, oxidation (refolding) of the linear
peptides, puri¢cation of synthetic inhibitors and amino acid
analysis were performed as described previously [14,17].
Yields of the synthetic and puri¢cation steps, HPLC analyses
and association equilibrium constants of the synthesized in-
hibitors with bovine L-trypsin are summarized in Table 1.
3.2. Determination of trypsin-inhibitor equilibrium association
constants
The association constants were measured by the method
developed in the laboratory of M. Laskowski, Jr. [18,19]. Bo-
vine L-trypsin-inhibitor interaction was determined in 0.1 M
Tris-HCl, pH 8.3 bu¡er containing 20 mM CaCl2 and 0.005%
Triton X-100 at 22‡C. The measurement was carried out at an
enzyme concentration of 3.01U10310 M. The inhibitor con-
centrations varied from 0 to 6.5U10310 M. The residual en-
zyme activity was measured with Bz-Val-Gly-Arg-4-nitroani-
lide as a substrate. Di¡erent conditions, due to signi¢cantly
lower Ka value, were applied for the analogue 5 ; enzyme
concentration 3.40U1038 M, inhibitor concentrations varied
from 0 to 7.40U1038 M. Bz-D,L-Arg-4-nitroanilide was used
as a substrate. In all cases the initial substrate concentration
was below 0.1 Km. The experiment data were analyzed based
on the residual enzyme concentration, [E], versus the initial
inhibitor concentration, [I]. The details of the non-linear least
square procedure are described elsewhere [19,20]. The inhib-
ition of bovine L-trypsin by the ¢ve new analogues is shown in
Fig. 3.
4. Results
As indicated in Table 1, with the exception of peptide 5, the
other four analogues showed a very strong trypsin inhibitory
activity. Their Ka values measured with bovine L-trypsin were
of the same order of magnitude as those obtained for the wild
CMTI-I and -III molecules. The last analogue 5, with Ala
residue in position 18, showed signi¢cantly lower inhibitory
activity (the Ka value was about three orders of magnitude
lower than that obtained for the other analogues). These re-
sults suggest that the side-chain interactions between Leu7 and
Tyr27 are less important for the inhibitor stabilization, but
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Fig. 1. The amino acid sequence and the disul¢de bridge connectiv-
ities for CMTI-I and CMTI-III.
Fig. 2. Stereo view of CMTI-I adopted from ¢le 2cti retrieved from Brookhaven Protein Data Bank [21]. Residues Val7, Tyr27 are marked by
bold lines.
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Fig. 3. Inhibition curves of bovine L-trypsin by; (a) analogue 1, (b) analogue 2, (c) analogue 3, (d) analogue 4, (e) analogue 5.
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probably only when Pro is present in position 18 (analogues
2^4).
In our previous papers [5,13] we demonstrated the role of
two L-turns present in the regions 17^20 and 23^26 on the
oxidation (refolding) yields. Based on those results we sug-
gested that the second region had stronger in£uence on the
refolding pathway and the stabilization of the three-dimen-
sional structure of CMTI inhibitors. Now, we assume that
the role of the ¢rst L-turn is more important. It is particularly
signi¢cant when we consider di¡erences in the inhibitory ac-
tivity of two pairs of analogues: 4/IP and 1/5, which were
found to be over ¢ve and three orders of magnitudes, respec-
tively. The analogues di¡er in one position only, Ala18 present
in IP and 5 was replaced by Pro in analogues 4 and 2. This
amino acid residue (Pro) was a part of the tripeptide Gly17-
Pro18-Gly19 which was introduced into CMTI-III analogues
for the promotion of the L-turn formation [13]. In the case of
analogues with Pro18 (2^4), the more important factor is the
e¡ect that stabilizes the L-turn in fragment 17^20. The role of
the hydrophobic interactions between positions discussed in
the stabilization of the three-dimensional structure is less pro-
nounced. The Ka values are of the same order of magnitude.
The presence of Ala (the amino acid residue with much great-
er conformational freedom) in position 18 might allow, when
the interaction between side chains of amino acid residues in
positions 7 and 27 are not strong enough, to adopt by the
binding loop a conformation which is not favorable for the
interaction with trypsin. In fact, Ala18 is present in the second
position of the type IIP L-turn in both, the complex of CMTI-
I-bovine L-trypsin [10] and in the structure of the free inhib-
itor as determined by the NMR method [11]. As already
stressed in both papers, this position in the type IIP L-turn
is very often occupied by Gly but not by Ala. In contrast to
what was observed for the analogues with Pro in position 18,
the in£uence on the inhibitory activity of the interaction be-
tween side chains of amino acid residues in positions 7 and 27
for the analogues with Ala in position 18 is rather signi¢cant.
The Ka value for analogue 5 is about three orders of magni-
tude lower than that obtained for the parent compound 1. In
both analogues a pair Leu7, Tyr27 is present. For the analogue
IP, which di¡ers from 5 basically in position 27 only, the
inhibitory activity was more than two orders of magnitude
lower. This re£ects the presence of an aliphatic pair Leu7,
Val27 in the ¢rst analogue. The interaction between side
chains of these amino acid residues is not strong enough to
form the conformation of the binding loop which would be
the most favorable for the interaction with the enzyme.
Another interesting point is that the interaction between the
amino acid residue in position 7 of the inhibitor and Phe41 of
trypsin can occur, giving a detectable energy contribution to
the enzyme-inhibitor stabilization. Both analogues with Tyr
instead of Leu in position 7 demonstrated about four times
higher Ka values. According to the X-ray study of the CMTI-
I-bovine L-trypsin complex, the primary contact segment of
the inhibitor runs antiparallel to the trypsin segment Ser214-
Gly216 [10], and the presence of the hydrogen bond between
inhibitor Leu7 and enzyme Phe41 has been pointed out. We
suppose that an aromatic amino acid residue (such as Tyr) in
position 7 of the inhibitor can also induce additional hydro-
phobic (aromatic-aromatic) interaction with the aromatic ring
of the trypsin Phe41 residue. According to Burley and Petsko
[22], such single aromatic-aromatic interaction contribute
about 1 Kcal/mol to the protein-protein complex stabilization.
This is in line with our results, which indicate that possible
aromatic-aromatic interaction of the inhibitor Tyr7 and the
enzyme Phe41 give about 0.8 Kcal/mol to the enzyme-inhibitor
complex stabilization, and also with theoretical calculations of
the energy interaction of the analogues discussed with bovine
L-trypsin (W. Brandt, Halle, Germany, personal communica-
tion).
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